How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
ARE YOU A COMMUNITY MEDICAL OR RADIATION ONCOLOGIST?
- Interested In Starting A Radiopharmaceutical Program At Your Center But Seems Complex?
- Interested In Conducting Radiopharmaceutical Clinical Trials But Have No Current Or Limited Clinical Trials Program
- Interested In Helping Fill The Critical Shortage Of Community Cancer Centers Capable Of Conducting Radiopharmaceutical Clinical Trials
XCancer® has the experts and the experience to provide your center with the backbone, tools, strategies, and business models to make you successful at both. XCancer® is a community cancer center with a solo medical oncologist that has developed a leading radiopharmaceutical clinical trials program recognized globally. Using its experience and processes, XCancer® has successfully guided community cancer centers across the United States with developing highly efficient and quality clinical trial programs.
Start your program today:
Physicians
Advanced Knowledge & Opportunites
- Advance your Knowledge of Theranostics, Radiation, & Clinical Trials
- Search a Comprehensive List of Global Oncology-Theranostic clinical trials
- Easy access to Publications & Presentations regarding investigational Theranostic agents
- Opportunities & Access to Strategy Advisors on How to Develop a Theranostic Clinical Trials Program at Your Site
- Access to Clinical Trials Sponsors in search of potential clinical trial sites
- Keep updated of Upcoming Theranostic Conferences
Distinguished Investigator
A Distinguished Investigator of Theranostics is a level of distinction conferred upon an individual physician who has demonstrated a mastery of conducting novel radioligand therapies and molecular imaging clinical trials.
RLT Components
RADIOLIGAND THERAPY (RLT) is a highly effective approach to very accurately locating cancer cells and effectively killing those same cells by delivery various radioisotopes to a specific target that is located on a type of cancer. Some of the Radioisotopes are diagnostic for locating cancers & some therapeutic to treat the cancers.
There are several Components to a RLT that are simply demonstrated in the truck diagram including:
- Cancer Targets
- Ligand (demonstrated as the Truck GPS set to find a specific Target)
- Diagnostic Radioisotopes (demonstrated as light bulbs that light the cancer Targets on a PET scan)
- Therapeutic Radioisotopes (demonstrated as bombs that kill cancer cells that express the target with either Alpha or Beta radiation)
- Linker (demonstrated as the hitch keeping the Radioisotope attached to the Ligand)
- Chelator (demonstrated as the Trailers which keeps the Radioisotope on Target).
To learn more about the specific components being studied today on clinical trials around the world check out the RLT COMPONENTS Tab.
Education
Stats
Theranostic Trials Global Ecosystem
View All
Conferences
JPM 44th Annual Healthcare Conference
Located at the Westin St. Francis Hotel, this premier conference is the largest and most informative healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. Health Community features the leading innovators and latest innovations from around the world which are addressing today’s health and wellness challenges. Learn how the latest advances, leading research and best practices are being applied to grow and scale digital health solutions.PepTalk – The Protein Science & Production Week
The world’s premier event for biotherapeutic discovery and development, PepTalk brings together industry leaders and academic pioneers to explore protein expression, production platforms, antibody engineering, and the newly added peptide/miniprotein track. Peptalk +1 Across four immersive days, attendees will engage in symposia, keynotes, poster sessions and networking—with topics ranging from AI/ML in biologics to multispecific antibodies and peptide therapeutics. Peptalk +1 Whether you’re optimizing biologic workflows or advancing oncology-targeted therapies, this event offers tools and connections to accelerate your pipeline.SNMMI Mid Winter & ACNM Conference
Each year, more than 500 attendees gather at the SNMMI Mid-Winter & ACNM Annual Meeting to collaborate with experts in the field, enhance their skills, and apply their newfound knowledge at their clinics. This event provides your company with an excellent chance to connect with leading professionals who are advancing precision medicine in an intimate setting.8th Theranostics World Congress
As we look forward to the 8th Theranostics World Congress (TWC2026), we are excited to unveil a refreshed and dynamic agenda that reflects the latest advancements and innovations in the field. This congress aims to explore new frontiers in theranostics, bringing together leading experts, researchers, and practitioners to share their insights and drive collaborative efforts.Multidisciplinary Radiopharmaceutical Therapy Symposium
The 2026 Multidisciplinary Radiopharmaceuticals Therapy Symposium is a live event held at the JW Marriott Palm Desert in California, February 17-18, 2026. There is both an in person and virtual option available. In-Person Full Meeting Registration includes access to all the educational sessions; admission to the Exhibit Hall including continental breakfast, lunch and coffee breaks; meeting materials and in-person networking with fellow attendees; plus, the ability to earn continuing medical education (CME) credits. Additionally, access to RPT onDemand is included in your registration. Virtual Full Meeting Registration includes real-time livestream access to the educational sessions taking place in the General Session room as they happen; the ability to interact with presenters during live sessions through Social Q&A; and the ability to earn continuing medical education (CME) credits. Access to RPT onDemand is included in your registration.2nd TRP Target Selection & Drug Design Summit
The 2nd TRP Target Selection & Drug Design Summit (Feb 24-26, 2026 | Boston, MA) is the only meeting devoted to next-generation radioligand therapy (RLT) design—bringing together target-discovery, isotope-pairing, vector design, and translation strategy under one roof. targeted-radiopharma-target-selection-drug-design.com +1 Over three days, attendees will dive into how to expand beyond conventional targets like PSMA/SSTR2, match isotopes to biology, improve tumor retention, minimise off-target toxicity (e.g., kidneys/salivary glands), and advance first-in-human translation. If your team is working on smarter vector design, newer radionuclides (alpha/beta/Auger), novel linkers/chelators, or translational strategy in oncology theranostics, this summit offers high-value networking and actionable insight.High Country Nuclear Medicine '26
The High Country Nuclear Medicine Conference (HCNMC) is an annual gathering focused on nuclear medicine and molecular imaging. The format: roughly 6-7 hours of structured sessions per day (~8 sessions total), along with round-table discussions and networking opportunities.36th Annual European Pharma Congress
Pharma Conferences is the best venue for discussing themes of shared interest in the field of pharma among academics, researchers, students, members of esteemed societies and institutes, as well as professionals from academia and the pharma industries. Over the span of two days, the extraordinary line-up of plenary speakers, keynote speakers, and other attendees at Pharma Europe 2026 will permit academics from all over the world to exhibit their research to leading international experts.EMIM 2026
The European Molecular Imaging Meeting (EMIM) is ESMI’s flagship gathering, uniting academics, clinical scientists and industry across molecular, functional and morphological imaging. The 2026 edition will be held 24-27 March in Ljubljana, Slovenia. With over 1,200 international participants expected, the program spans cutting-edge research, interactive young-investigator events and sessions on image-guided therapy and theranosticsPSMA and Beyond
The PSMA & Beyond Conference, co-hosted by the University of California, Los Angeles (UCLA) and the University of California, San Francisco (UCSF), with support from the Prostate Cancer Foundation (PCF), will focus on the current and future use of PET imaging and radionuclide therapy, including presentations, panel discussions, and exhibits from invited speakers and stakeholders.ESRR '26
The ESRR Symposium is the annual gathering organised by the European Society of Radiopharmacy and Radiochemistry (ESRR).The symposium features a mix of invited lectures, “back-to-basics” educational sessions, oral & poster abstract sessions, industry exhibitions and social/networking events.22nd European Symposium On Radiopharmacy and Radiopharmaceuticals
The European Society of Radiopharmacy and Radiochemistry are hosting their annual meeting on April 16-19, 2026 in Bergen, Norway.13th Balkan Congress of Nuclear Medicine
This conference provides solid fundaments as well as cutting edge technologies and methods for both diagnosis and treatment in the field of Oncology, Cardiology, Endocrinology and virtually any field of human medicine.NMN 2026
The NMN Symposium (May 7-8, 2026, Vienna) convenes leading nuclear-medicine and neuro-oncology experts to explore the latest advances in molecular imaging and theranostics for CNS malignancies. With sessions on PET RANO criteria, alpha-emitters in brain tumors, and trial design in neuro-oncology theranostics, the event provides high-impact clinical and translational insights.PEGS Boston '26
The PEGS Summit is the leading global event in biologics and protein/antibody engineering, bringing together researchers, industry leaders and technology providers to advance drug development through innovation. With over 20 conference tracks, training seminars, and breakout sessions, the 2026 edition (May 11-15, Boston, MA) will cover topics such as antibodies for cancer therapy, radiopharmaceutical therapy, emerging peptides, and AI/ML- driven biologics research.Theranostics Europe
Theranostics Europe 2026 brings together leading experts from nuclear medicine, radiopharmaceuticals, and molecular imaging to explore the evolving landscape of targeted diagnostics and therapy. Held on March 25–26 in the Netherlands, the conference will highlight translational breakthroughs, clinical applications, and innovation in radiotheranostics, bridging science and patient care in precision oncology and beyond.ASCO 2026 Annual Meeting
The 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO), held May 29–June 2, 2026 at McCormick Place in Chicago, Illinois, is one of the premier global gatherings in the field of oncology. Organized by ASCO, the world’s leading professional society for cancer clinicians and researchers, this five-day event brings together tens of thousands of oncology professionals from around the world to share groundbreaking research, clinical insights, and emerging treatment strategies that are shaping the future of cancer care. The program will feature over 200 sessions complementing Dr. Eric Small’s Presidential theme, The Science and Practice of Translation: Improving Cancer Outcomes Worldwide.2026 SNMMI Annual Meeting
2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting is organized by Society of Nuclear Medicine and Molecular Imaging (SNMMI) and will be held at Los Angeles, California, United States of America.ICRR 2026
International Conference on Radiopharmacy and Radiopharmaceuticals is being held in Riga, Latvia. The International Conference on Radiopharmacy and Radiopharmaceuticals aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Radiopharmacy and Radiopharmaceuticals. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Radiopharmacy and Radiopharmaceuticals.Building Momentum for Targeted Metal-Based Therapeutics and Diagnostics
The conference takes place 21-26 June 2026 at Proctor Academy in Andover, New Hampshire, and brings together scientists working on metallodrugs, metal-based diagnostics/therapeutics, radionuclide applications and inorganic imaging agents. Its key focus is on advancing targeted metal-based therapeutics and diagnostics, including sessions on drug activation, delivery strategies, radionuclides, imaging modalities and metal ion regulation in disease.Radiopharmaceutical Strategies for Tumor Targeting and Microenvironment Modulation
Join leading scientists, clinicians, physicists and industry experts at the 2026 Radionuclide Theranostics for the Management of Cancer GRC (July 12–17, 2026) at Sunday River, Maine. The conference focuses on cutting-edge, unpublished research in radionuclide therapies and theranostics for cancer, providing extended discussion time and an immersive, small-group format. Attendees will gain deep insights into new radionuclides, ligands, immuno-targets and translational models—ideal for organisations advancing imaging-guided therapy in oncology.Theranostics Reimagined: Interrogating Biology, Empowering Translation
The Radionuclide Theranostics for the Management of Cancer GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes an array of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.Prostic 2026
Join the global theranostics community at ProsTIC26 (3-5 September 2026, Melbourne) — a premier educational event focused on prostate cancer theranostics. Through case-based discussions, multidisciplinary sessions and next-generation target/ligand insights, delegates from urology, oncology, nuclear medicine, radiopharmacy and physics will explore the real-world impact of theranostics.PDDS 2026
The Global Conference on Pharmaceutics and Novel Drug Delivery Systems explores next-generation drug formulation, targeted delivery, and biotherapeutic technologies. With its hybrid format and diverse scientific agenda, this event connects pharma innovators shaping the future of therapeutics and personalized medicine.International Conference on Radiopharmaceutical Therapy (ICRT)
ICRT 2026 celebrates the unifying power of science—bringing together clinicians, radiopharmacists, physicists, regulators, and industry to advance equitable access to personalized radiopharmaceutical therapy worldwide.Terachem 2026
The Fifth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine will take place 23-26 September 2026 in Bressanone (BZ), Italy. It focuses on advances in radiometal chemistry, radiopharmaceutical development (especially with technetium and other radiometals)ICC 2026
Magnus Group’s International Cancer Conference will take place October 8-10 2026 in Tokyo (hybrid format) under the theme “From Prevention to Survivorship.” It spans prevention, diagnostics, therapy, and survivorship across molecular oncology, immunotherapy, and precision medicine.EANM '26
The EANM Annual Congress is the flagship scientific meeting of the (EANM). It brings together a globally diverse audience of nuclear-medicine professionals, researchers, technologists, industry partners and policy-makers.ESMO 2026
The ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2025 will be a place where groundbreaking discoveries, cutting-edge treatments and a collaborative approach converge to shape the future of cancer care.2026 Therapeutics Conference
2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Therapeutics Conference is organized by Society of Nuclear Medicine and Molecular Imaging (SNMMI) and will be held from Nov 04 - 08, 2026 at Bethesda, Maryland, United States of America.ICPO Virtual Theranostics Summit
Virtual conference with international experts from academia and industry in the field of theranostics in precision oncology.ICRR 2026
The conference is scheduled for December 20-21, 2026 in Honolulu, United States, and will be held as a hybrid event. It brings together academic scientists, industry researchers and practitioners to present original work on all aspects of radiopharmacy and radiopharmaceuticals—including PET/SPECT agents, therapeutic radiopharmaceuticals, regulatory affairs and radiopharmacy practice.Sponsors
.svg)
